SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Emmaus Life Sciences, Inc. – ‘10-Q’ for 12/31/15 – ‘EXCEL’

On:  Tuesday, 2/16/16, at 5:33pm ET   ·   As of:  2/17/16   ·   For:  12/31/15   ·   Accession #:  1615774-16-4225   ·   File #:  1-35527

Previous ‘10-Q’:  ‘10-Q’ on 8/14/15 for 6/30/15   ·   Next:  ‘10-Q’ on 5/16/16 for 3/31/16   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/17/16  Emmaus Life Sciences, Inc.        10-Q       12/31/15   71:5.5M                                   S2 Filings LLC/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    378K 
 2: EX-10.27    Material Contract                                   HTML     83K 
 3: EX-10.28    Material Contract                                   HTML     38K 
 4: EX-10.29    Material Contract                                   HTML     50K 
 5: EX-10.30    Material Contract                                   HTML     37K 
 6: EX-10.31    Material Contract                                   HTML    111K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
16: R1          Document and Entity Information                     HTML     46K 
17: R2          Unaudited Condensed Consolidated Statements of      HTML     80K 
                Operations                                                       
18: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     95K 
19: R4          Condensed Consolidated Balance Sheets (Unaudited)   HTML     39K 
                (Parenthetical)                                                  
20: R5          Unaudited Condensed Consolidated Statements of      HTML     83K 
                Cash Flows                                                       
21: R6          Unaudited Condensed Consolidated Statements of      HTML     43K 
                Stockholders' Deficit                                            
22: R7          Nature of Operations                                HTML     37K 
23: R8          Summary of Significant Accounting Policies          HTML     81K 
24: R9          Discontinued Operations                             HTML     45K 
25: R10         Convertible Debt and Equity Financings              HTML     59K 
26: R11         Derivative Liabilities                              HTML     58K 
27: R12         Stockholders' Deficit                               HTML    111K 
28: R13         Related Party Transactions                          HTML     72K 
29: R14         Loss Per Share                                      HTML     41K 
30: R15         Commitments and Contingent Liabilities              HTML     50K 
31: R16         Subsequent Events                                   HTML     26K 
32: R17         Summary of Significant Accounting Policies          HTML    135K 
                (Policies)                                                       
33: R18         Summary of Significant Accounting Policies          HTML     52K 
                (Tables)                                                         
34: R19         Discontinued Operations (Tables)                    HTML     43K 
35: R20         Convertible Debt and Equity Financings (Tables)     HTML     40K 
36: R21         Derivative Liabilities (Tables)                     HTML     58K 
37: R22         Stockholders' Deficit (Tables)                      HTML     99K 
38: R23         Related Party Transactions (Tables)                 HTML     30K 
39: R24         Loss Per Share (Tables)                             HTML     38K 
40: R25         Commitments and Contingent Liabilities (Tables)     HTML     34K 
41: R26         Nature of Operations (Details Narrative)            HTML     42K 
42: R27         Summary of Significant Accounting Policies          HTML     51K 
                (Details Narrative)                                              
43: R28         Summary of Significant Accounting Policies          HTML     30K 
                (Details)                                                        
44: R29         Summary of Significant Accounting Policies          HTML     33K 
                (Details 1)                                                      
45: R30         Discontinued Operations (Details)                   HTML     43K 
46: R31         Discontinued Operations (Details 1)                 HTML     33K 
47: R32         Convertible Debt and Equity Financings (Details     HTML    171K 
                Narrative)                                                       
48: R33         Convertible Debt and Equity Financings (Details)    HTML     77K 
49: R34         Derivative Liabilities (Details Narrative)          HTML     67K 
50: R35         Derivative Liabilities (Details)                    HTML     30K 
51: R36         Derivative Liabilities (Details 1)                  HTML     42K 
52: R37         Derivative Liabilities (Details 2)                  HTML     30K 
53: R38         Derivative Liabilities (Details 3)                  HTML     27K 
54: R39         Stockholders' Deficit (Details Narrative)           HTML    106K 
55: R40         Stockholders' Deficit (Details Narrative 1)         HTML     54K 
56: R41         Stockholders' Deficit (Details)                     HTML     28K 
57: R42         Stockholders' Deficit (Details 1)                   HTML     37K 
58: R43         Stockholders' Deficit (Details 2)                   HTML     89K 
59: R44         Stockholders' Deficit (Details 3)                   HTML     42K 
60: R45         Stockholders' Deficit (Details 4)                   HTML     69K 
61: R46         Stockholders' Deficit (Details 5)                   HTML     31K 
62: R47         Related Party Transactions (Details Narrative)      HTML    170K 
63: R48         Related Party Transactions (Details Narrative 1)    HTML    218K 
64: R49         Related Party Transactions (Details)                HTML     49K 
65: R50         Loss Per Share (Details)                            HTML     53K 
66: R51         Commitments and Contingent Liabilities (Details     HTML     47K 
                Narrative)                                                       
67: R52         Commitments and Contingent Liabilities (Details)    HTML     56K 
68: R53         Subsequent Events (Details Narrative)               HTML     42K 
70: XML         IDEA XML File -- Filing Summary                      XML    120K 
69: EXCEL       IDEA Workbook of Financial Reports                  XLSX     82K 
10: EX-101.INS  XBRL Instance -- cnso-20151231                       XML   1.64M 
12: EX-101.CAL  XBRL Calculations -- cnso-20151231_cal               XML    135K 
13: EX-101.DEF  XBRL Definitions -- cnso-20151231_def                XML    714K 
14: EX-101.LAB  XBRL Labels -- cnso-20151231_lab                     XML    918K 
15: EX-101.PRE  XBRL Presentations -- cnso-20151231_pre              XML    886K 
11: EX-101.SCH  XBRL Schema -- cnso-20151231                         XSD    144K 
71: ZIP         XBRL Zipped Folder -- 0001615774-16-004225-xbrl      Zip    137K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook

Top
Filing Submission 0001615774-16-004225   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 4:58:13.1pm ET